Novel anti-inflammatory drug shows early promise in treating Long COVID cognitive symptoms, fatigue, PEM. The study looked at multiple endpoints and consulted with people living with the disease.
Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.Britta Shoot ...
This summer’s COVID-19 wave is still lingering into the fall, as much of the country reports ongoing moderate to high disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results